Illustration of a lung Xray with doctors looking it over, and aspirin on the ground to symbolize AERD

FAIRFAX, VA, SEPT. 12, 2023 – Aspirin-Exacerbated Respiratory Disease (AERD) is becoming more recognized as a chronic medical condition. Patient advocacy organizations continue to lead efforts to raise awareness of the disease.

Allergy & Asthma Network announces that AERD Awareness Day is Tuesday, Sept. 26. What is the purpose of AERD Awareness Day? It is to encourage patients and healthcare professionals to be vigilant with:

  • getting an accurate diagnosis;
  • understanding AERD symptoms;
  • treating and managing the condition.

Since AERD is a rare disease, it is difficult for patients to find doctors who are knowledgeable about it.

Some AERD symptoms, including loss of sense of smell, are also symptoms of COVID-19. Talk with your doctor when symptoms flare. Consider getting tested for COVID-19.

What is AERD?

AERD involves three conditions:

  • asthma
  • recurrent nasal polyps
  • sensitivity to aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs)

AERD affects approximately 1.2 million to 1.6 million people in the United States. It is also known as Samter’s Triad. AERD often develops in adulthood, usually between the ages of 20 and 50. Symptoms sometimes do not respond to conventional treatments.

On AERD Awareness Day, Allergy & Asthma Network distributes patient education resources. Our newest publication is “Your AERD Medical Management Appointment Guide.” It helps you prepare patients for doctor’s appointments, and more. The Network also provides free posters for healthcare professionals.

Learn more about AERD